Brooke E Nichols

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models

Jeffrey W. Eaton, Nicolas A. Menzies, John Stover et al. · The Lancet Global Health · 2013 · 246 citations · Full text

Pharmacy, Health Policy, Pharmacoeconomics +17

Population density and basic reproductive number of COVID-19 across United States counties

Karla Therese L. Sy, Laura F. White, Brooke E Nichols · PLoS ONE · 2021 · 222 citations · Full text

Veterinary Medicine, Infectious Diseases, Population Health Sciences +16

Sustainable HIV treatment in Africa through viral-load-informed differentiated care

Andrew Phillips, Amir Shroufi, Lara Vojnov et al. · Nature · 2015 · 168 citations · Full text

Public Health, Infectious Diseases, Pharmacoeconomics +17

Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study

Brooke E Nichols, Charles A. Boucher, Marc van der Valk et al. · The Lancet Infectious Diseases · 2016 · 109 citations

Pharmacy, Pharmacoeconomics, Preventive Medicine +17

Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron

Karlijn van der Straten, Denise Guerra, Marit J. van Gils et al. · Immunity · 2022 · 99 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15